Asia · News · The Korea Herald

GI Innovation starts Japan phase 2 trial of allergy drug

Published by The Korea Herald · South Korea 8 h ago

GI Innovation said Wednesday that the first patient in a Japanese phase 2 trial of its allergy treatment candidate GI-301 is scheduled to receive the drug this ...

Read the full article on The Korea Herald Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.koreaherald.com)

Also worth reading

The Straits Times

Climate change strips island’s title of largest penguin colony: Study

Yonhap

Vance points to S. Korea's 'political dynamics' amid uncertainty over Alaska LNG project

South China Morning Post

France halts use of stun grenades in policing of student protests

CNA

US FCC to vote on advancing new spectrum auction to boost 'direct to device' services

NDTV

Donald Trump's Own SIR? How An American Voter-Citizenship Mass Check Takes Cue From India

Hindustan Times